UniProt ID | AF1L2_HUMAN | |
---|---|---|
UniProt AC | Q8N4X5 | |
Protein Name | Actin filament-associated protein 1-like 2 | |
Gene Name | AFAP1L2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 818 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | May play a role in a signaling cascade by enhancing the kinase activity of SRC. Contributes to SRC-regulated transcription activation.. | |
Protein Sequence | MERYKALEQLLTELDDFLKILDQENLSSTALVKKSCLAELLRLYTKSSSSDEEYIYMNKVTINKQQNAESQGKAPEEQGLLPNGEPSQHSSAPQKSLPDLPPPKMIPERKQLAIPKTESPEGYYEEAEPYDTSLNEDGEAVSSSYESYDEEDGSKGKSAPYQWPSPEAGIELMRDARICAFLWRKKWLGQWAKQLCVIKDNRLLCYKSSKDHSPQLDVNLLGSSVIHKEKQVRKKEHKLKITPMNADVIVLGLQSKDQAEQWLRVIQEVSGLPSEGASEGNQYTPDAQRFNCQKPDIAEKYLSASEYGSSVDGHPEVPETKDVKKKCSAGLKLSNLMNLGRKKSTSLEPVERSLETSSYLNVLVNSQWKSRWCSVRDNHLHFYQDRNRSKVAQQPLSLVGCEVVPDPSPDHLYSFRILHKGEELAKLEAKSSEEMGHWLGLLLSESGSKTDPEEFTYDYVDADRVSCIVSAAKNSLLLMQRKFSEPNTYIDGLPSQDRQEELYDDVDLSELTAAVEPTEEATPVADDPNERESDRVYLDLTPVKSFLHGPSSAQAQASSPTLSCLDNATEALPADSGPGPTPDEPCIKCPENLGEQQLESLEPEDPSLRITTVKIQTEQQRISFPPSCPDAVVATPPGASPPVKDRLRVTSAEIKLGKNRTEAEVKRYTEEKERLEKKKEEIRGHLAQLRKEKRELKETLLKCTDKEVLASLEQKLKEIDEECRGEESRRVDLELSIMEVKDNLKKAEAGPVTLGTTVDTTHLENVSPRPKAVTPASAPDCTPVNSATTLKNRPLSVVVTGKGTVLQKAKEWEKKGAS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
33 | 2-Hydroxyisobutyrylation | LSSTALVKKSCLAEL CCCCHHHHHHHHHHH | 39.56 | - | |
44 | Phosphorylation | LAELLRLYTKSSSSD HHHHHHHHHCCCCCC | 12.99 | 27273156 | |
47 | Phosphorylation | LLRLYTKSSSSDEEY HHHHHHCCCCCCCCE | 27.87 | 26356563 | |
48 | Phosphorylation | LRLYTKSSSSDEEYI HHHHHCCCCCCCCEE | 35.10 | 26356563 | |
49 | Phosphorylation | RLYTKSSSSDEEYIY HHHHCCCCCCCCEEE | 49.23 | 26356563 | |
50 | Phosphorylation | LYTKSSSSDEEYIYM HHHCCCCCCCCEEEE | 51.49 | 26356563 | |
54 | Phosphorylation | SSSSDEEYIYMNKVT CCCCCCCEEEEEEEE | 8.70 | 19060924 | |
56 | Phosphorylation | SSDEEYIYMNKVTIN CCCCCEEEEEEEEEC | 8.17 | 27273156 | |
61 | Phosphorylation | YIYMNKVTINKQQNA EEEEEEEEECCCCCH | 22.05 | 26356563 | |
96 | Phosphorylation | HSSAPQKSLPDLPPP CCCCCCCCCCCCCCC | 39.63 | 28348404 | |
119 | Phosphorylation | LAIPKTESPEGYYEE CCCCCCCCCCCCCCC | 33.22 | 9449045 | |
124 | Phosphorylation | TESPEGYYEEAEPYD CCCCCCCCCCCCCCC | 20.39 | 138541 | |
158 | Phosphorylation | EDGSKGKSAPYQWPS CCCCCCCCCCCCCCC | 43.05 | 25106551 | |
161 | Phosphorylation | SKGKSAPYQWPSPEA CCCCCCCCCCCCHHH | 23.95 | 25106551 | |
165 | Phosphorylation | SAPYQWPSPEAGIEL CCCCCCCCHHHHHHH | 32.20 | 22777824 | |
208 | Phosphorylation | NRLLCYKSSKDHSPQ CEEEEEECCCCCCCC | 19.02 | 23312004 | |
209 | Phosphorylation | RLLCYKSSKDHSPQL EEEEEECCCCCCCCC | 37.64 | 23312004 | |
213 | Phosphorylation | YKSSKDHSPQLDVNL EECCCCCCCCCCHHH | 25.19 | 25056879 | |
223 | Phosphorylation | LDVNLLGSSVIHKEK CCHHHHCHHHHCHHH | 22.77 | 23312004 | |
224 | Phosphorylation | DVNLLGSSVIHKEKQ CHHHHCHHHHCHHHH | 24.24 | 23312004 | |
278 | Phosphorylation | GLPSEGASEGNQYTP CCCCCCCCCCCCCCC | 57.82 | 28348404 | |
283 | Phosphorylation | GASEGNQYTPDAQRF CCCCCCCCCCCHHHH | 25.00 | 27251275 | |
284 | Phosphorylation | ASEGNQYTPDAQRFN CCCCCCCCCCHHHHC | 12.62 | 25056879 | |
301 | Phosphorylation | KPDIAEKYLSASEYG CCHHHHHHCCHHHHC | 9.44 | 23090842 | |
303 | Phosphorylation | DIAEKYLSASEYGSS HHHHHHCCHHHHCCC | 27.02 | 25394399 | |
305 | Phosphorylation | AEKYLSASEYGSSVD HHHHCCHHHHCCCCC | 28.16 | 25106551 | |
307 | Phosphorylation | KYLSASEYGSSVDGH HHCCHHHHCCCCCCC | 21.58 | 25394399 | |
309 | Phosphorylation | LSASEYGSSVDGHPE CCHHHHCCCCCCCCC | 26.70 | 25106551 | |
310 | Phosphorylation | SASEYGSSVDGHPEV CHHHHCCCCCCCCCC | 21.62 | 23090842 | |
320 | Phosphorylation | GHPEVPETKDVKKKC CCCCCCCCCCHHHHH | 26.86 | 27307780 | |
332 | Methylation | KKCSAGLKLSNLMNL HHHCCCCHHHHHHHC | 49.29 | - | |
334 | Phosphorylation | CSAGLKLSNLMNLGR HCCCCHHHHHHHCCC | 26.74 | 101663561 | |
344 | Phosphorylation | MNLGRKKSTSLEPVE HHCCCCCCCCCCCCH | 26.68 | 29255136 | |
345 | Phosphorylation | NLGRKKSTSLEPVER HCCCCCCCCCCCCHH | 46.33 | 29255136 | |
346 | Phosphorylation | LGRKKSTSLEPVERS CCCCCCCCCCCCHHH | 37.51 | 29255136 | |
353 | Phosphorylation | SLEPVERSLETSSYL CCCCCHHHHHCHHHH | 19.63 | 28442448 | |
356 | Phosphorylation | PVERSLETSSYLNVL CCHHHHHCHHHHHHH | 28.41 | 28442448 | |
357 | Phosphorylation | VERSLETSSYLNVLV CHHHHHCHHHHHHHH | 13.96 | 28442448 | |
358 | Phosphorylation | ERSLETSSYLNVLVN HHHHHCHHHHHHHHC | 40.85 | 24872395 | |
359 | Phosphorylation | RSLETSSYLNVLVNS HHHHCHHHHHHHHCC | 11.32 | 27259358 | |
383 | Phosphorylation | RDNHLHFYQDRNRSK HHCCEEEEECCCCHH | 9.96 | 21082442 | |
397 | Phosphorylation | KVAQQPLSLVGCEVV HHCCCCHHHCCCEEC | 27.91 | 26356563 | |
408 | Phosphorylation | CEVVPDPSPDHLYSF CEECCCCCCCCEEEE | 50.79 | 29255136 | |
413 | Phosphorylation | DPSPDHLYSFRILHK CCCCCCEEEEEEEEC | 11.44 | 29255136 | |
414 | Phosphorylation | PSPDHLYSFRILHKG CCCCCEEEEEEEECC | 17.89 | 29255136 | |
431 | Phosphorylation | LAKLEAKSSEEMGHW HHHHCCCCHHHHHHH | 50.45 | 50563843 | |
432 | Phosphorylation | AKLEAKSSEEMGHWL HHHCCCCHHHHHHHH | 36.55 | 50563851 | |
456 | Phosphorylation | KTDPEEFTYDYVDAD CCCHHHHCCCEECHH | 20.82 | 30814731 | |
457 | Phosphorylation | TDPEEFTYDYVDADR CCHHHHCCCEECHHH | 15.59 | 25106551 | |
459 | Phosphorylation | PEEFTYDYVDADRVS HHHHCCCEECHHHHH | 6.99 | 25348954 | |
466 | Phosphorylation | YVDADRVSCIVSAAK EECHHHHHHHHHHHH | 10.06 | 30835091 | |
470 | Phosphorylation | DRVSCIVSAAKNSLL HHHHHHHHHHHHHHH | 11.55 | 25348954 | |
484 | Phosphorylation | LLMQRKFSEPNTYID HHHHHHCCCCCCCCC | 56.00 | 28355574 | |
488 | Phosphorylation | RKFSEPNTYIDGLPS HHCCCCCCCCCCCCC | 32.35 | 30108239 | |
489 | Phosphorylation | KFSEPNTYIDGLPSQ HCCCCCCCCCCCCCH | 12.03 | 30108239 | |
537 | Phosphorylation | ERESDRVYLDLTPVK CCCCCCEEEECCCCH | 8.73 | 25394399 | |
541 | Phosphorylation | DRVYLDLTPVKSFLH CCEEEECCCCHHHHC | 26.21 | 19664994 | |
545 | Phosphorylation | LDLTPVKSFLHGPSS EECCCCHHHHCCCCC | 33.02 | 30206219 | |
551 | Phosphorylation | KSFLHGPSSAQAQAS HHHHCCCCCHHHHCC | 42.79 | 28387310 | |
552 | Phosphorylation | SFLHGPSSAQAQASS HHHCCCCCHHHHCCC | 27.77 | 30206219 | |
558 | Phosphorylation | SSAQAQASSPTLSCL CCHHHHCCCCCCHHH | 25.44 | 28857561 | |
559 | Phosphorylation | SAQAQASSPTLSCLD CHHHHCCCCCCHHHH | 25.56 | 28857561 | |
561 | Phosphorylation | QAQASSPTLSCLDNA HHHCCCCCCHHHHCH | 33.00 | 28857561 | |
563 | Phosphorylation | QASSPTLSCLDNATE HCCCCCCHHHHCHHH | 18.34 | 30206219 | |
569 | Phosphorylation | LSCLDNATEALPADS CHHHHCHHHCCCCCC | 28.22 | 25002506 | |
576 | Phosphorylation | TEALPADSGPGPTPD HHCCCCCCCCCCCCC | 49.33 | 25002506 | |
600 | Phosphorylation | LGEQQLESLEPEDPS CCHHHHHHCCCCCCC | 46.77 | 113326983 | |
617 | Phosphorylation | ITTVKIQTEQQRISF EEEEEEEECHHCCCC | 38.95 | 23312004 | |
623 | Phosphorylation | QTEQQRISFPPSCPD EECHHCCCCCCCCCC | 33.61 | 23312004 | |
627 | Phosphorylation | QRISFPPSCPDAVVA HCCCCCCCCCCCEEE | 38.22 | 28102081 | |
635 | Phosphorylation | CPDAVVATPPGASPP CCCCEEECCCCCCCC | 20.57 | 22777824 | |
640 | Phosphorylation | VATPPGASPPVKDRL EECCCCCCCCHHHHE | 35.33 | 29255136 | |
650 | Phosphorylation | VKDRLRVTSAEIKLG HHHHEEEEHEEEECC | 18.78 | 27794612 | |
651 | Phosphorylation | KDRLRVTSAEIKLGK HHHEEEEHEEEECCC | 22.50 | 54886155 | |
668 | Phosphorylation | TEAEVKRYTEEKERL CHHHHHHHHHHHHHH | 16.88 | 72499757 | |
669 | Phosphorylation | EAEVKRYTEEKERLE HHHHHHHHHHHHHHH | 41.52 | 72499763 | |
697 | Acetylation | RKEKRELKETLLKCT HHHHHHHHHHHHHCC | 43.85 | 18527893 | |
728 | Phosphorylation | EECRGEESRRVDLEL HHHCCCHHHCCCEEE | 22.53 | 29449344 | |
736 | Phosphorylation | RRVDLELSIMEVKDN HCCCEEEEEEEHHHH | 15.54 | 24505115 | |
753 | Phosphorylation | KAEAGPVTLGTTVDT HHCCCCEEECCEEEC | 23.70 | 23312004 | |
756 | Phosphorylation | AGPVTLGTTVDTTHL CCCEEECCEEECCCH | 27.10 | 28348404 | |
757 | Phosphorylation | GPVTLGTTVDTTHLE CCEEECCEEECCCHH | 18.00 | 28348404 | |
760 | Phosphorylation | TLGTTVDTTHLENVS EECCEEECCCHHCCC | 16.27 | 28348404 | |
761 | O-linked_Glycosylation | LGTTVDTTHLENVSP ECCEEECCCHHCCCC | 21.72 | 30379171 | |
761 | Phosphorylation | LGTTVDTTHLENVSP ECCEEECCCHHCCCC | 21.72 | 28348404 | |
767 | Phosphorylation | TTHLENVSPRPKAVT CCCHHCCCCCCCCCC | 27.12 | 25850435 | |
774 | Phosphorylation | SPRPKAVTPASAPDC CCCCCCCCCCCCCCC | 20.28 | 10401181 | |
788 | Phosphorylation | CTPVNSATTLKNRPL CCCCCCCCCCCCCCC | 32.27 | 10401193 | |
796 | Phosphorylation | TLKNRPLSVVVTGKG CCCCCCCEEEEECCC | 18.62 | 28731282 | |
800 | Phosphorylation | RPLSVVVTGKGTVLQ CCCEEEEECCCCHHH | 22.90 | 23312004 | |
804 | Phosphorylation | VVVTGKGTVLQKAKE EEEECCCCHHHHHHH | 22.87 | 23312004 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
54 | Y | Phosphorylation | Kinase | RET | P07949 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AF1L2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AF1L2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-668 AND THR-669, ANDMASS SPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-413, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-383 AND TYR-413, ANDMASS SPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-413, AND MASSSPECTROMETRY. |